Recruiting Lymphoma Studies in Camperdown
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112â„¢ in subjects with relapsed or refractory B-cell malignancies....
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
This trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma....
About Lymphoma Clinical Trials in Camperdown
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Camperdown, NEW%20SOUTH%20WALES. These studies are seeking a combined 228 participants. Research is being sponsored by CRISPR Therapeutics AG, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Camperdown — FAQ
Are there lymphoma clinical trials in Camperdown?
Yes, there are 2 lymphoma clinical trials currently recruiting in Camperdown, NEW%20SOUTH%20WALES. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Camperdown?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Camperdown research site will contact you about next steps.
Are clinical trials in Camperdown free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Camperdown studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Camperdown are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov